Frederic Oberti

Angers, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications

Implementation and evaluation of an ambulatory care pathway for intra-arterial treatment of primary liver cancer: study protocol for a multicentre randomised controlled hybrid type 1 trial (CHOC).

Implementation and evaluation of an ambulatory care pathway for intra-arterial treatment of primary liver cancer: study protocol for a multicentre randomised controlled hybrid type 1 trial (CHOC).

Journal: BMJ open
Published: August 06, 2026

FIB-4: a simple blood test to identify patients at risk of liver complications

FIB-4: a simple blood test to identify patients at risk of liver complications

Journal: La Revue du praticien
Published: May 05, 2026

Laparoscopic or Open Liver Resection Versus Multibipolar Radiofrequency Ablation of HCC Within Milan Criteria on Cirrhosis.

Laparoscopic or Open Liver Resection Versus Multibipolar Radiofrequency Ablation of HCC Within Milan Criteria on Cirrhosis.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 18, 2025

Second-line practices in the era of immunotherapy in HCC: The CHIEF cohort.

Second-line practices in the era of immunotherapy in HCC: The CHIEF cohort.

Journal: JHEP reports : innovation in hepatology
Published: October 20, 2025

Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with early hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial).

Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with early hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial).

Journal: Hepatology (Baltimore, Md.)
Published: October 16, 2025

Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy.

Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy.

Journal: European journal of gastroenterology & hepatology
Published: August 13, 2025

A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY Data.

A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY Data.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: July 08, 2025

Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial.

Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial.

Journal: The lancet. Gastroenterology & hepatology
Published: March 28, 2025

Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial.

Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial.

Journal: Journal of hepatology
Published: November 29, 2024

Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort.

Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 28, 2024

French guidelines on TIPS: Indications and modalities.

French guidelines on TIPS: Indications and modalities.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 12, 2024

MASLD-related HCC: Multicenter study comparing patients with and without cirrhosis.

MASLD-related HCC: Multicenter study comparing patients with and without cirrhosis.

Journal: JHEP reports : innovation in hepatology
Published: January 31, 2024
Showing 1-12 of 77

Last Updated: 09/26/2026